Proteomic analysis of outer membrane vesicles derived from the type A5 Strain of Mannheimia haemolytica

Ke Shang1,2,3, Yuanji Gao2,3, Jiangbo Du1

  • 1The 989th Hospital of the Joint Logistics Support Force of Chinese People's Liberation Army, Luoyang, China.

Insights

Mannheimia haemolytica outer membrane vesicles (OMVs) were studied. These OMVs enhance inflammatory responses, offering insights for developing vaccines and antibiotics against M. haemolytica infections.

Area of Science:

  • Veterinary Microbiology
  • Bacterial Pathogenesis
  • Immunology

Background:

  • Mannheimia haemolytica causes significant economic losses in livestock through mastitis, sepsis, and bovine respiratory disease.
  • Understanding M. haemolytica pathogenesis is vital for disease control.
  • Outer membrane vesicles (OMVs) are key bacterial mediators, but their role in M. haemolytica is unclear.

Purpose of the Study:

  • To investigate the role of OMVs in M. haemolytica pathogenesis.
  • To characterize OMVs from the M. haemolytica Type A5 strain (MH-5).
  • To assess the immunogenic and inflammatory potential of MH-5 OMVs.

Main Methods:

  • Isolation and characterization of OMVs from MH-5 using ultracentrifugation.
  • Electron microscopy for OMV visualization.
  • Proteomic analysis (LC-MS/MS) for protein composition.
  • Cellular experiments to assess inflammatory cytokine mRNA expression (IL-1β, IL-6, TNF-α).

Main Results:

  • MH-5 strain secretes OMVs under natural conditions.
  • OMVs contain 282 proteins, enriched in immunity, iron metabolism, and catalytic functions.
  • OMVs significantly increase inflammatory cytokine mRNA expression in a dose-dependent manner.

Conclusions:

  • MH-5 OMVs contribute to the inflammatory response during M. haemolytica infection.
  • These findings provide a basis for understanding M. haemolytica pathogenesis.
  • OMVs represent potential targets for novel vaccines and therapeutics against M. haemolytica.

Related Concept Videos